Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Aditxt, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 14 | 12 | −2 |
| Shares | 699.0K | 67.2K | −631.8K (−90.4%) |
| Value | $313.8K | $826.4K | +$512.6K (+163.3%) |
New holders (4)
Institutions that held Aditxt, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 33,900 | $423.4K | 0.00% |
| Armistice Capital, LLC | 28,000 | $349.7K | 0.01% |
| Qube Research & Technologies Ltd | 1,200 | $15.0K | 0.00% |
| UBS Group AG | 809 | $10.1K | 0.00% |
Sold out (6)
Institutions that held Aditxt, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Sabby Management, LLC | 589,560 | $265.3K |
| Vanguard Group Inc | 46,465 | $20.9K |
| State Street Corp | 37,900 | $17.1K |
| JPMorgan Chase & Co | 2,106 | $948 |
| Ronald Blue Trust, Inc. | 22 | $0 |
| Valley National Advisers Inc | 50 | – |